Novel mechanism of enhanced nociception in a model of AIDS therapy-induced painful peripheral neuropathy in the rat
- PMID: 14715401
- DOI: 10.1016/j.pain.2003.10.010
Novel mechanism of enhanced nociception in a model of AIDS therapy-induced painful peripheral neuropathy in the rat
Abstract
To elucidate the underlying mechanisms involved in AIDS therapy-induced peripheral neuropathy, we have developed a model of nucleoside analog reverse transcriptase inhibitor-induced painful peripheral neuropathy in the rat, using 2',3'-dideoxycytidine (ddC), 2',3'-dideoxyinosine (ddI) and 2',3'-didehydro-3'-deoxythymidine (d4T), AIDS chemotherapeutic drugs that are also components of AIDS highly active anti-retroviral therapy. Administration of ddC, ddI and d4T produced dose-dependent mechanical hypersensitivity and allodynia. Peripheral administration of inhibitors of protein kinase A, protein kinase C, protein kinase G, p42/p44-mitogen-activated protein kinase (ERK1/2) and nitric oxide synthase, which have demonstrated anti-hyperalgesic effects in other models of metabolic and toxic painful peripheral neuropathies, had no effect on ddC-, ddI- and d4T-induced hypersensitivity. Since suramin, an anti-parasitic and anti-cancer drug, which shares with the anti-retroviral nucleoside analogs, mitochondrial toxicity, altered regulation of intracellular calcium, and a sensory neuropathy in humans, also produced mechanical hypersensitivity that was not sensitive to the above second messenger inhibitors we evaluated the role of intracellular calcium. Intradermal or spinal injection of intracellular calcium modulators (TMB-8 and Quin-2), which had no effect on nociception in control rats, significantly attenuated and together eliminated ddC and suramin-induced mechanical hypersensitivity. In electrophysiology experiments in ddC-treated rats, C-fibers demonstrated alterations in pattern of firing as indicated by changes in the distribution of interspike intervals to sustained suprathreshold stimuli without change in mechanical activation thresholds or in number of action potentials in response to threshold and suprathreshold stimulation. This study provides evidence for a novel, calcium-dependent, mechanism for neuropathic pain in a model of AIDS therapy-induced painful peripheral neuropathy.
Similar articles
-
Spinal RyR2 pathway regulated by the RNA-binding protein HuD induces pain hypersensitivity in antiretroviral neuropathy.Exp Neurol. 2015 May;267:53-63. doi: 10.1016/j.expneurol.2015.02.036. Epub 2015 Mar 10. Exp Neurol. 2015. PMID: 25765490
-
Mechanically-evoked C-fiber activity in painful alcohol and AIDS therapy neuropathy in the rat.Mol Pain. 2007 Feb 23;3:5. doi: 10.1186/1744-8069-3-5. Mol Pain. 2007. PMID: 17319957 Free PMC article.
-
Characterization of rodent models of HIV-gp120 and anti-retroviral-associated neuropathic pain.Brain. 2007 Oct;130(Pt 10):2688-702. doi: 10.1093/brain/awm195. Epub 2007 Aug 30. Brain. 2007. PMID: 17761732 Free PMC article.
-
Recent advances in drug-induced neuropathies.Curr Opin Neurol. 2002 Oct;15(5):633-8. doi: 10.1097/00019052-200210000-00015. Curr Opin Neurol. 2002. PMID: 12352008 Review.
-
Cutaneous pain in disorders affecting peripheral nerves.Neurosci Lett. 2021 Nov 20;765:136233. doi: 10.1016/j.neulet.2021.136233. Epub 2021 Oct 1. Neurosci Lett. 2021. PMID: 34506882 Free PMC article. Review.
Cited by
-
IL-10 mediated by herpes simplex virus vector reduces neuropathic pain induced by HIV gp120 combined with ddC in rats.Mol Pain. 2014 Jul 30;10:49. doi: 10.1186/1744-8069-10-49. Mol Pain. 2014. PMID: 25078297 Free PMC article.
-
Suppression of inflammatory and neuropathic pain by uncoupling CRMP-2 from the presynaptic Ca²⁺ channel complex.Nat Med. 2011 Jun 5;17(7):822-9. doi: 10.1038/nm.2345. Nat Med. 2011. PMID: 21642979 Free PMC article.
-
Identification of Key Genes and Pathways in Mouse Spinal Cord Involved in ddC-Induced Neuropathic Pain by Transcriptome Sequencing.J Mol Neurosci. 2021 Mar;71(3):651-661. doi: 10.1007/s12031-020-01686-6. Epub 2020 Aug 18. J Mol Neurosci. 2021. PMID: 32812184
-
The effect of the palmitoylethanolamide analogue, palmitoylallylamide (L-29) on pain behaviour in rodent models of neuropathy.Br J Pharmacol. 2007 Aug;151(7):1117-28. doi: 10.1038/sj.bjp.0707326. Epub 2007 Jun 11. Br J Pharmacol. 2007. PMID: 17558434 Free PMC article.
-
Gene therapy with HSV encoding p55TNFR gene for HIV neuropathic pain: an evidence-based mini-review.Transl Perioper Pain Med. 2017;2(4):24-32. Transl Perioper Pain Med. 2017. PMID: 29130055 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous